ethylnitrosourea has been researched along with Tyrosinemias in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Dhalimy, M; Finegold, M; Grompe, M; Manning, K | 1 |
Aponte, JL; Carpenter, DA; Culiat, CT; Dhar, MS; Hauser, LJ; Johnson, DK; Rinchik, EM; Sega, GA; Withrow, CM | 1 |
2 other study(ies) available for ethylnitrosourea and Tyrosinemias
Article | Year |
---|---|
In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I.
Topics: Acetoacetates; Alanine Transaminase; Animals; Cloning, Molecular; Crosses, Genetic; Disease Models, Animal; Ethylnitrosourea; Gene Conversion; Gene Deletion; Genotype; Heterozygote; Liver; Loss of Heterozygosity; Mice; Mice, Knockout; Models, Genetic; Mutagenesis; Precancerous Conditions; Reverse Transcriptase Polymerase Chain Reaction; Suppression, Genetic; Tyrosine; Tyrosinemias | 1999 |
Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Topics: Acute Disease; Alleles; Amino Acid Substitution; Animals; Animals, Newborn; Base Sequence; Biomarkers; Chronic Disease; Crosses, Genetic; DNA, Complementary; Enzyme Induction; Ethylnitrosourea; Exons; Female; Frameshift Mutation; Genes; Genes, Lethal; Heptanoates; Humans; Hydrolases; Kidney; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Animal; Molecular Sequence Data; Mutagenesis; Mutation, Missense; Point Mutation; RNA Splicing; RNA, Messenger; Tyrosinemias | 2001 |